XML 22 R7.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Cash flows from operating activities:      
Net loss $ (45,470) $ (49,000) $ (49,857)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:      
Depreciation and amortization 7,628 6,725 5,352
Amortization of debt discount 0 0 1,129
Stock-based compensation expense 19,541 17,316 10,685
Provision for doubtful accounts 905 931 828
Impairment of long-lived assets 0 0 483
Deferred income taxes (2,860) 75 119
Foreign currency re-measurement (gain) loss (364) 58 153
Other non-cash expenses 209 222 209
Changes in assets and liabilities:      
Accounts receivable (25,217) (6,195) (18,370)
Prepaid expenses and other assets (74) (3,523) (1,787)
Accounts payable (2,257) 1,619 (2,302)
Accrued expenses 6,758 1,578 6,702
Deferred revenue 55,437 38,748 44,868
Other liabilities (950) 558 (119)
Net cash provided by (used in) operating activities 13,286 9,112 (1,907)
Cash flows from investing activities:      
Business acquisitions, net of cash acquired (14,717) 0 (38,811)
Purchases of property and equipment (4,824) (4,499) (4,136)
Capitalization of internal-use software (1,162) 0 0
Purchases of investments (35,190) (38,976) 0
Sales and maturities of investments 33,672 0 0
Increase in restricted cash (200) 0 0
Net cash used in investing activities (22,421) (43,475) (42,947)
Cash flows from financing activities:      
Proceeds from initial public offering and concurrent private placement, net of offering costs of $3,097 0 0 112,275
Repayments of term loan and related termination fee 0 0 (18,540)
Deferred business acquisition payment (796) (1,392) 0
Payments of capital lease obligations 0 (68) (253)
Taxes paid related to net share settlement of equity awards (698) (4,114) 0
Excess tax benefit from stock-based compensation 0 87 0
Proceeds from employee stock purchase plan 2,914 3,724 0
Proceeds from stock option exercises 5,848 2,924 1,304
Net cash provided by financing activities 7,268 1,161 94,786
Effect of exchange rate changes on cash and cash equivalents 281 (203) (202)
Net (decrease) increase in cash and cash equivalents (1,586) (33,405) 49,730
Cash and cash equivalents, beginning of period 53,148 86,553 36,823
Cash and cash equivalents, end of period 51,562 53,148 86,553
Supplemental cash flow information:      
Cash paid for income taxes 801 556 341
Cash paid for interest 0 5 1,427
Supplemental non-cash investing and financing information:      
Common stock issued for acquisitions 0 0 27,481
Vested stock options issued for acquisition $ 0 $ 0 $ 4,494